Step 1: Define Your Goals Weight Loss Target: Need to lose 20-40 pounds: Semaglutide sufficient (14.9% average loss) Less expensive option works well Compounded semaglutide at $199/month Need to lose 50+ pounds: Tirzepatide preferred (22.5% average loss) Maximum effectiveness important Compounded tirzepatide at $349/month Need to lose 100+ pounds: Tirzepatide strongly recommended May still need bariatric surgery after medication Medication can help even if surgery eventual goal Timeline: Want faster results: Tirzepatide produces weight loss slightly faster But both require 16-20 months for full results No medication produces safe, sustainable rapid weight loss Have time for gradual approach: Either medication works Semaglutide more affordable for extended timeline Step 2: Assess Your Health Status Medical Conditions: Type 2 Diabetes: Both semaglutide and tirzepatide excellent choices Provide blood sugar control plus weight loss May allow reducing other diabetes medications Cardiovascular Disease: Semaglutide proven to reduce heart attacks/strokes (SELECT trial) May be preferred if heart disease history Tirzepatide cardiovascular trial ongoing Thyroid Cancer or MEN 2 History: Absolute contraindication to all GLP-1s Must use non-GLP-1 options (phentermine-topiramate) Gastrointestinal Disorders: GLP-1s may worsen gastroparesis Consider if severe GERD or chronic GI issues Discuss with provider Pregnancy Plans: Do not use GLP-1s if pregnant or planning pregnancy Stop 2 months before trying to conceive Choose non-GLP-1 option or delay treatment Previous Pancreatitis: Relative contraindication to GLP-1s Use with caution, close monitoring May be safer to avoid Current Medications: Insulin or Sulfonylureas: GLP-1s may cause low blood sugar when combined Need to reduce diabetes medication doses Close monitoring required Blood Thinners: GLP-1s safe with anticoagulants No contraindication Psychiatric Medications: Generally compatible with GLP-1s Naltrexone-bupropion may have more interactions Step 3: Evaluate Your Budget What Can You Afford Long-Term
Although the FDA has yet to approve BPC 157 for medical use, the growing body of anecdotal evidence and clinical reports suggests that these peptides hold promise in a variety of treatments
Elevated GLP-1 Levels in Patients With APS Researchers measured GLP-1 and GLP-1R levels in blood and cerebrospinal fluid samples from 248 patients with NMOSD, including 57 with APS, and 164 healthy controls
In both cases, it can cause a misuse of the medication
Maintaining a healthy weight has long been considered an important part of breast cancer prevention because excess body weight, especially after menopause, is a well-established risk factor
Soom Lite is a reduced-sugar fruit juice that is infused with an EFSA-backed Japanese plant fibre, and this particular all-natural plant fibre can visibly curb sugar spikes when consumed with meals
